Literature DB >> 19218576

Remote implantable cardioverter defibrillator monitoring in a Brugada syndrome population.

Frédéric Sacher1, Vincent Probst, Maider Bessouet, Matthew Wright, Alexandre Maluski, Sélim Abbey, Pierre Bordachar, Antoine Deplagne, Sylvain Ploux, Gilles Lande, Pierre Jaïs, Mélèze Hocini, Michel Haïssaguerre, Hervé Le Marec, Jacques Clémenty.   

Abstract

AIMS: The diagnosis of Brugada syndrome (BS) is typically made in a young and otherwise healthy population. In patients with a high risk of sudden cardiac death (SCD), the only currently recommended therapy is an implantable cardioverter defibrillator (ICD), but these are not without complications. We investigated whether remote ICD monitoring could simplify follow-up and detect potential complications in these patients. METHODS AND
RESULTS: Thirty-five consecutive patients (26 males, 44 +/- 11 years) implanted with an ICD for BS with a remote monitoring ['Home Monitoring' (HM), Biotronik, Germany] system were prospectively enrolled in this study. They were matched for age, sex, and follow-up duration with 35 BS patients implanted with an ICD without this capability. During a mean follow-up of 33 +/- 17 months, the number of cardiology consultations was significantly lower in the HM group (3 +/- 2 vs. 7 +/- 3; P < 0.001). Inappropriate shock(s) [IS(s)] occurred in three patients (8.5%) in the HM group vs. six (17%) in the control group (P = NS). Ten patients in the HM group had a median of four alerts ('ventricular tachycardia/ventricular fibrillation detection' in all patients, 'shock' in three, 'ineffective shock' in two patients with shock on noise, 'extreme ventricular pacing impedance' in one patient due to lead failure, and 'deactivated therapy' in two patients with lead failure before replacement). In 5 of these 10 patients, prompt reprogramming of the ICD may have prevented IS(s).
CONCLUSION: Remote ICD monitoring in patients with BS decreases outpatient consultations and may help prevent ISs.

Entities:  

Mesh:

Year:  2009        PMID: 19218576     DOI: 10.1093/europace/eup034

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  17 in total

Review 1.  J-Wave syndromes expert consensus conference report: Emerging concepts and gaps in knowledge.

Authors:  Charles Antzelevitch; Gan-Xin Yan; Michael J Ackerman; Martin Borggrefe; Domenico Corrado; Jihong Guo; Ihor Gussak; Can Hasdemir; Minoru Horie; Heikki Huikuri; Changsheng Ma; Hiroshi Morita; Gi-Byoung Nam; Frederic Sacher; Wataru Shimizu; Sami Viskin; Arthur A M Wilde
Journal:  Europace       Date:  2017-04-01       Impact factor: 5.214

Review 2.  Internet-based device-assisted remote monitoring of cardiovascular implantable electronic devices: an evidence-based analysis.

Authors:  G Pron; L Ieraci; K Kaulback
Journal:  Ont Health Technol Assess Ser       Date:  2012-01-01

Review 3.  J-Wave syndromes expert consensus conference report: Emerging concepts and gaps in knowledge.

Authors:  Charles Antzelevitch; Gan-Xin Yan; Michael J Ackerman; Martin Borggrefe; Domenico Corrado; Jihong Guo; Ihor Gussak; Can Hasdemir; Minoru Horie; Heikki Huikuri; Changsheng Ma; Hiroshi Morita; Gi-Byoung Nam; Frederic Sacher; Wataru Shimizu; Sami Viskin; Arthur A M Wilde
Journal:  Heart Rhythm       Date:  2016-07-13       Impact factor: 6.343

Review 4.  J wave syndromes as a cause of malignant cardiac arrhythmias.

Authors:  José M Di Diego; Charles Antzelevitch
Journal:  Pacing Clin Electrophysiol       Date:  2018-06-30       Impact factor: 1.976

5.  Guideline of the Brazilian Society of Cardiology on Telemedicine in Cardiology - 2019.

Authors:  Marcelo Antônio Cartaxo Queiroga Lopes; Gláucia Maria Moraes de Oliveira; Antonio Luiz Pinho Ribeiro; Fausto J Pinto; Helena Cramer Veiga Rey; Leandro Ioschpe Zimerman; Carlos Eduardo Rochitte; Fernando Bacal; Carisi Anne Polanczyk; Cidio Halperin; Edson Correia Araújo; Evandro Tinoco Mesquita; José Airton Arruda; Luis Eduardo Paim Rohde; Max Grinberg; Miguel Moretti; Paulo Ricardo Avancini Caramori; Roberto Vieira Botelho; Andréa Araújo Brandão; Ludhmila Abrahão Hajjar; Alexandre Fonseca Santos; Alexandre Siciliano Colafranceschi; Ana Paula Beck da Silva Etges; Bárbara Campos Abreu Marino; Bruna Stella Zanotto; Bruno Ramos Nascimento; Cesar Rocha Medeiros; Daniel Vitor de Vasconcelos Santos; Daniela Matos Arrowsmith Cook; Eduardo Antoniolli; Erito Marques de Souza Filho; Fábio Fernandes; Fabio Gandour; Francisco Fernandez; Germano Emilio Conceição Souza; Guilherme de Souza Weigert; Iran Castro; Jamil Ribeiro Cade; José Albuquerque de Figueiredo Neto; Juliano de Lara Fernandes; Marcelo Souza Hadlich; Marco Antonio Praça Oliveira; Maria Beatriz Alkmim; Maria Cristina da Paixão; Maurício Lopes Prudente; Miguel A S Aguiar Netto; Milena Soriano Marcolino; Monica Amorim de Oliveira; Osvaldo Simonelli; Pedro A Lemos Neto; Priscila Raupp da Rosa; Renato Minelli Figueira; Roberto Caldeira Cury; Rodrigo Coelho Almeida; Sandra Regina Franco Lima; Silvio Henrique Barberato; Thiago Inocêncio Constancio; Wladimir Fernandes de Rezende
Journal:  Arq Bras Cardiol       Date:  2019-11       Impact factor: 2.000

6.  Prevention of inappropriate ICD shocks in patients with Brugada syndrome.

Authors:  Christian Veltmann; Juergen Kuschyk; Rainer Schimpf; Florian Streitner; Nina Schoene; Martin Borggrefe; Christian Wolpert
Journal:  Clin Res Cardiol       Date:  2009-09-16       Impact factor: 5.460

Review 7.  Remote monitoring of patients with implanted cardiac devices.

Authors:  Fred Kusumoto; Nora Goldschlager
Journal:  Clin Cardiol       Date:  2010-01       Impact factor: 2.882

Review 8.  Pharmacological Therapy in Brugada Syndrome.

Authors:  Oholi Tovia Brodie; Yoav Michowitz; Bernard Belhassen
Journal:  Arrhythm Electrophysiol Rev       Date:  2018-06

9.  Atrial fibrillation in cardiac channelopathies.

Authors:  Jayachandran Thejus; Johnson Francis
Journal:  Indian Pacing Electrophysiol J       Date:  2009-11-01

10.  Ageing and Brugada syndrome: considerations and recommendations.

Authors:  Pieter G Postema; Hanno L Tan; Arthur Am Wilde
Journal:  J Geriatr Cardiol       Date:  2013-03       Impact factor: 3.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.